TrademarkDir
PTI
DEAD

Serial Number

86742486

Owner

Proteostasis Therapeutics, Inc.

Attorney

John L. DuPre'

First Use Date

Jan 14, 2013

Filing Date

Aug 31, 2015

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PTI Trademark

Serial Number: 86742486 • Registration: 5751554

PTI is a trademark filed by Proteostasis Therapeutics, Inc. on August 31, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Proteostasis Therapeutics, Inc. (9 trademarks)

Boston, MA 02135

Entity Type: 03

Trademark Details

Filing Date

August 31, 2015

Registration Date

May 14, 2019

First Use Anywhere

January 14, 2013

First Use in Commerce

January 14, 2013

Published for Opposition

February 2, 2016

Cancellation Date

November 28, 2025

Goods & Services

Pharmaceutical preparations for the treatment of respiratory conditions, diseases, syndromes and disorders

Chemicals for scientific research purposes for synthesizing small molecule compounds; proteostasis regulators, namely, chemical preparations for scientific research; chemical additives for use in the manufacture of pharmaceuticals; cells for scientific and medical research; reagents for use in genetic research

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 28, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 14, 2024 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 23, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 23, 2019 REAP
REGISTERED-PRINCIPAL REGISTER
May 14, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 6, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 5, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 5, 2019 SUPC
USE AMENDMENT FILED
Mar 28, 2019 IUAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 28, 2019 TCCA
TEAS STATEMENT OF USE RECEIVED
Mar 28, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 14, 2018 EXRA
SOU EXTENSION 5 GRANTED
Sep 13, 2018 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 13, 2018 AITU
SOU EXTENSION 5 FILED
Sep 5, 2018 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 5, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 14, 2018 EXRA
SOU EXTENSION 4 GRANTED
Feb 12, 2018 EX4G
SOU EXTENSION 4 FILED
Feb 12, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 12, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2017 EXRA
SOU EXTENSION 3 GRANTED
Sep 8, 2017 EX3G
SOU EXTENSION 3 FILED
Sep 8, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 8, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 29, 2017 EXRA
SOU EXTENSION 2 GRANTED
Mar 27, 2017 EX2G
SOU EXTENSION 2 FILED
Mar 27, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 27, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 1, 2016 EXRA
SOU EXTENSION 1 GRANTED
Sep 29, 2016 EX1G
SOU EXTENSION 1 FILED
Sep 29, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 29, 2016 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 19, 2016 TCCA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 29, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 2, 2016 NPUB
PUBLISHED FOR OPPOSITION
Feb 2, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 13, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 19, 2015 CNSA
ASSIGNED TO EXAMINER
Dec 14, 2015 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 4, 2015 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 3, 2015 NWOS
NEW APPLICATION ENTERED
Sep 3, 2015 NWAP

Related Trademarks

More from this Owner

#CFORWARD

#CFORWARD

#CFORWARD

#CFORWARD

PROTEOSTASIS THERAPEUTICS

PROTEOSTASIS THERAPEUTICS

PROTEOSTASIS THERAPEUTICS

PROTEOSTASIS THERAPEUTICS

PTI PROTEOSTASIS THERAPEUTICS, INC. logo

PTI PROTEOSTASIS THERAPEUTICS, INC.

PTI logo

PTI